See the DrugPatentWatch profile for Sevelamer
Sevelamer is a phosphate binder used to manage hyperphosphatemia in patients with chronic kidney disease [1]. It belongs to the class of non-calcium, non-aluminum phosphate binders [2].
How does sevelamer work to lower phosphate levels?
Sevelamer works in the gastrointestinal tract by binding to dietary phosphate and preventing its absorption into the bloodstream [1]. This binding occurs through an ion-exchange mechanism and hydrogen bonding, where the positively charged amine groups of sevelamer bind to negatively charged phosphate molecules [3].
What are the different forms of sevelamer available?
Sevelamer is available in two formulations: sevelamer hydrochloride and sevelamer carbonate [4]. These formulations differ in their chemical composition but serve the same therapeutic purpose [4].
What are the potential side effects of sevelamer?
Common side effects associated with sevelamer use include gastrointestinal issues such as nausea, vomiting, diarrhea, constipation, and abdominal pain [1]. Less common side effects can include rash, itching, and muscle pain [1]. Long-term effects, particularly regarding vitamin absorption, are also a consideration [5].
How does sevelamer compare to other phosphate binders?
Sevelamer is an alternative to calcium-based phosphate binders, which can lead to hypercalcemia and vascular calcification in some patients [2]. Unlike calcium-based binders, sevelamer does not contribute to calcium overload. It also differs from aluminum-based binders, which can cause aluminum toxicity with prolonged use [2]. Other non-calcium, non-aluminum binders include lanthanum carbonate [2].
When does sevelamer's patent protection expire?
Information regarding the specific patent expiry dates for sevelamer products can be found on resources like DrugPatentWatch.com [6]. Patent protection is a key factor in determining when generic versions of the drug can enter the market [6].
Are there generic alternatives to sevelamer?
Yes, generic versions of sevelamer are available, which can offer cost savings to patients and healthcare systems [7]. The availability of generics depends on the expiry of patent protections and regulatory approvals [7].
What is the typical cost of sevelamer?
The cost of sevelamer can vary depending on the formulation, dosage, and whether a generic or brand-name product is used [7]. Insurance coverage and pharmacy pricing also play a significant role in the out-of-pocket cost for patients [7].
What clinical studies support the use of sevelamer?
Numerous clinical trials have evaluated the efficacy and safety of sevelamer in managing hyperphosphatemia across different patient populations with chronic kidney disease [1][5]. These studies contribute to understanding its role in patient outcomes, including effects on bone mineral metabolism and cardiovascular health [5].